Production (Stage)
CNS Pharmaceuticals, Inc.
CNSP
$0.811
$0.00370.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.93% | -7.34% | 367.49% | 82.97% | 48.57% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.47% | 233.51% | -39.10% | -18.95% | -6.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -23.42% | 60.12% | -- | -- |
| Total Current Assets | 58.48% | 17.20% | 244.37% | 33.98% | 0.63% |
|
|
|||||
| Total Current Assets | 58.48% | 17.20% | 244.37% | 33.98% | 0.63% |
| Net Property, Plant & Equipment | -18.33% | 114.29% | -22.22% | -16.28% | -12.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.46% | 97.83% | -94.26% | 479.20% | -47.23% |
| Total Assets | 58.02% | 17.43% | 200.06% | 48.67% | -2.35% |
|
|
|||||
| Total Accounts Payable | 16.84% | -45.39% | -39.37% | 12.95% | 0.79% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -35.39% | 945.19% | -74.68% | -42.19% | -29.16% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.10% | -37.78% | -40.01% | 11.02% | -0.68% |
|
|
|||||
| Total Current Liabilities | 10.10% | -37.78% | -40.01% | 11.02% | -0.68% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -35.39% | 945.19% | -74.68% | -42.19% | -29.16% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.10% | -37.78% | -40.01% | 11.02% | -0.68% |
|
|
|||||
| Common Stock & APIC | 10.04% | 7.09% | 18.57% | 3.88% | 5.44% |
| Retained Earnings | -5.09% | -3.91% | -7.41% | -3.46% | -5.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 77.61% | 84.25% | 178.08% | 3.09% | 0.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 77.61% | 84.25% | 178.08% | 3.09% | 0.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 77.61% | 84.25% | 178.08% | 3.09% | 0.04% |
|
|
|||||